Patents by Inventor Roger Gay

Roger Gay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957754
    Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: April 16, 2024
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Judson Ratliff, Romma E. Southwick
  • Publication number: 20240026419
    Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.
    Type: Application
    Filed: July 6, 2023
    Publication date: January 25, 2024
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Irina Klimanskaya, Roger Gay
  • Publication number: 20230408489
    Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.
    Type: Application
    Filed: May 12, 2023
    Publication date: December 21, 2023
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
  • Patent number: 11739366
    Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: August 29, 2023
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Irina V. Klimanskaya, Roger Gay
  • Patent number: 11680941
    Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: June 20, 2023
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
  • Publication number: 20230051804
    Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 16, 2023
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
  • Patent number: 11422125
    Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: August 23, 2022
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Irina V. Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
  • Publication number: 20210275673
    Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.
    Type: Application
    Filed: March 23, 2021
    Publication date: September 9, 2021
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Judson Ratliff, Romma E. Southwick
  • Patent number: 11013808
    Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: May 25, 2021
    Assignee: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Judson Ratliff, Romma E. Southwick
  • Publication number: 20200405767
    Abstract: This disclosure provides the first description of hESC-derived cells transplanted into human patients. Results are reported for one patient with each of Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD). Controlled hESC differentiation resulted in near-100% pure RPE populations. Immediately after surgery, hyperpigmentation was visible at the transplant site in both patients, with subsequent evidence the cells had attached and integrated into the native RPE layer. No signs of inflammation or hyperproliferation were observed. The hESC-derived RPE cells have shown no signs of rejection or tumorigenicity at the time of this report. Visual measurements suggest improvement in both patients.
    Type: Application
    Filed: July 13, 2020
    Publication date: December 31, 2020
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Irina V. Klimanskaya, Robert P. Lanza
  • Publication number: 20190358330
    Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.
    Type: Application
    Filed: August 18, 2016
    Publication date: November 28, 2019
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Judson Ratliff, Romma E. Southwick
  • Publication number: 20190030168
    Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.
    Type: Application
    Filed: August 18, 2016
    Publication date: January 31, 2019
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Roger Gay, Judson Ratliff, Romma E. Southwick
  • Publication number: 20180052150
    Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.
    Type: Application
    Filed: March 23, 2016
    Publication date: February 22, 2018
    Inventors: Irina V. Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
  • Patent number: 9286574
    Abstract: A computer-implemented method for layered training of machine-learning architectures includes receiving a plurality of data elements wherein each data element is associated with a timestamp, determining a training window for each model layer of a layered stack of model layers, determining a plurality of training data elements for each training window by identifying the data elements with timestamps corresponding to each of the training windows, identifying a previous checkpoint for each model layer wherein the previous checkpoint for each model layer is generated by a parent model layer, training each model layer with the determined training data elements for each model layer and the identified previous checkpoint for each model layer, generating a plurality of current checkpoints wherein each current checkpoint of the plurality of current checkpoints is associated with a model layer, and storing the plurality of current checkpoints at the memory.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: March 15, 2016
    Assignee: Google Inc.
    Inventors: David Roger Gay, Paul Church, Russell O'Connor, Vinay Chaudhary, Yaroslav Litus
  • Publication number: 20150366915
    Abstract: This disclosure provides the first description of hESC-derived cells transplanted into human patients. Results are reported for one patient with each of Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD). Controlled hESC differentiation resulted in near-100% pure RPE populations. Immediately after surgery, hyperpigmentation was visible at the transplant site in both patients, with subsequent evidence the cells had attached and integrated into the native RPE layer. No signs of inflammation or hyperproliferation were observed. The hESC-derived RPE cells have shown no signs of rejection or tumorigenicity at the time of this report. Visual measurements suggest improvement in both patients.
    Type: Application
    Filed: May 15, 2015
    Publication date: December 24, 2015
    Applicant: Ocata Therapeutics, Inc.
    Inventors: Roger Gay, Irina V. Klimanskaya, Robert P. Lanza
  • Publication number: 20150127590
    Abstract: A computer-implemented method for layered training of machine-learning architectures includes receiving a plurality of data elements wherein each data element is associated with a timestamp, determining a training window for each model layer of a layered stack of model layers, determining a plurality of training data elements for each training window by identifying the data elements with timestamps corresponding to each of the training windows, identifying a previous checkpoint for each model layer wherein the previous checkpoint for each model layer is generated by a parent model layer, training each model layer with the determined training data elements for each model layer and the identified previous checkpoint for each model layer, generating a plurality of current checkpoints wherein each current checkpoint of the plurality of current checkpoints is associated with a model layer, and storing the plurality of current checkpoints at the memory.
    Type: Application
    Filed: November 4, 2013
    Publication date: May 7, 2015
    Applicant: Google Inc.
    Inventors: David Roger Gay, Paul Church, Russell O'Connor, Vinay Chaudhary, Yaroslav Litus
  • Publication number: 20130302824
    Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.
    Type: Application
    Filed: July 25, 2011
    Publication date: November 14, 2013
    Applicant: Advanced Cell Technology, Inc.
    Inventors: Irina Klimanskaya, Roger Gay